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Postoperative pulmonary embolism in a three 
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Abstract: Massive pulmonary embolism (PE) in a small child is a rare event and uniﬁ  ed 
guidelines for its treatment are missing. Timely diagnosis and management of massive pulmonary 
embolism is of crucial importance for a good outcome. We describe a unique management 
of PE causing oxygenation failure using a combination of catheter extraction technique, and 
regional thrombolysis on top of systemic heparin administration and inferior vena cava ﬁ  lter 
placement. Pulmonary hypertension was treated with inhaled nitric oxide. We believe that 
catheter extraction technique and regional thrombolysis is an option to consider provided that 
resources and expertise are available. Preoperative placement of an inferior vena cava ﬁ  lter 
should be contemplated in such high risk situations.
Keywords: embolectomy, regional thrombolysis, inferior vena cava ﬁ  lter, inhaled nitric oxide
Introduction
Klippel–Trenaunay syndrome (KTS) is a rare congenital anomaly characterized by 
venous and lymphatic abnormalities, cutaneous capillary malformations, and hyper-
trophy of soft tissue and bone. KTS is usually isolated to one extremity; however any 
part of the body may be affected. Deep venous thrombosis (DVT) with a pulmonary 
embolism (PE) has been described in these patients,1 though children have a lower 
rate of thromboembolic episodes. We report a life-threatening PE and its management 
in a child after radical resection of a KTS vascular malformation involving the right 
calf and adjacent tissues.
Case report
A 3-year-old boy (weight 22 kg), with KTS involving the right lower extremity, pelvis 
and genitalia was admitted to the medical-surgical intensive care unit (MSICU) after 
resection of his right lower extremity malformation. Except of his malformation he 
was a healthy child with normal kidney and liver function tests and no underlying 
pathology in hemostasis. The operation lasted 8.5 hours and was complicated by 
major blood loss (estimated blood loss 3400 mL). The patient remained intubated 
because of extensive volume resuscitation with blood products (2265 mL packed 
red blood cells, 436 mL fresh frozen plasma, and 6 units of platelets) and crystalloid 
(8900 mL). Patient was anticoagulated with low molecular weight heparin (LMWH), 
enoxaparin, for a few weeks prior to surgery. The drug was discontinued the day 
before the operation, and restarted on postoperative day (POD) 1 at a dose of 10 mg 
subcutaneously twice per day. On POD 2 a peripherally inserted central catheter 
was placed, active diuresis was initiated, and he began to wean from mechanical 
ventilation. On POD 3 the patient experienced a sudden episode of agitation, oxygen 
desaturation to 55%, and drop of end tidal partial pressure of carbon dioxide (pETCO2) 
from 40 s to 24 mmHg. Oxygenation slowly improved to 90% after administration 
of 100% oxygen and an increase in positive end-expiratory pressure (PEEP) from International Medical Case Reports Journal 2009:2 2
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5 mmHg to 16 mmHg. An arterial blood gas revealed a partial 
pressure of carbon dioxide (paCO2) of 75 mmHg and partial 
pressure of oxygen (paO2) of 62 mmHg on a FiO2 of 1.0. 
PE was suspected and immediate systemic anticoagulation 
with unfractionated heparin (UFH) was initiated using a 
bolus dose of 80 units/kg followed by an infusion at a rate of 
18 units/kg/hour. Urgent pulmonary CT angiography showed 
a large ﬁ  lling defect in the right main pulmonary artery (PA) 
(Figure 1) and a number of smaller defects in the peripheral 
PA branches. In light of respiratory instability the patient was 
transferred to the interventional radiology suite. Pulmonary 
arteriogram via the right internal jugular vein conﬁ  rmed a 
large thrombus in the right PA. A successful transcatheter 
pulmonary embolectomy was followed by thrombolysis with 
2 mg of recombinant tissue plasminogen activator (tPA), 
alteplase, injected through the PA catheter. The same dose 
of alteplase was repeated once and an inferior vena cava 
(IVC) ﬁ  lter was placed. Post-procedure angiogram revealed 
recanalized right PA with persistent smaller defects in upper 
and lower lobe branches. Systemic heparinization with 
UFH continued during thrombolysis as well as after arrival 
to MSICU. Heparinization was monitored by measuring 
heparin levels with a goal of  0.3–0.5 units/mL. Trans-thoracic 
echocardiogram (TTE) conﬁ  rmed a dilated right ventricle 
(RV) with elevated PA pressure (mean PA pressure equaled 
 –½ of mean systemic pressure) and dopamine 5 μg/kg/min 
was initiated to support RV function. Treatment with inhaled 
nitric oxide (iNO) started for pulmonary hypertension as 
well as for ventilation perfusion (VQ) mismatch. Within 
24 hours, the patient experienced an episode of hypoten-
sion and deterioration of gas exchange (Table 1); however, 
follow-up pulmonary angiography showed no new emboli, 
unchanged angiogram, and a still elevated PA pressure of 
32/22 mmHg. Patient was resuscitated with intravenous 
crystalloids and dopamine and epinephrine was added for a 
short period of time. Three days after the embolectomy, the 
patient bled extensively and required multiple blood trans-
fusions. Heparin was discontinued and pressure dressings 
were applied. No coagulation factors were transfused and 
protamine was not administered. UFH levels drifted to a 
value less than 0.05 units/min. After resolution of bleeding 
UFH drip was resumed. A follow-up TTE conﬁ  rmed good 
biventricular function with normal PA pressures. Patient 
was weaned off dopamine, iNO, and extubated within the 
Figure 1 Filling defect in the right main pulmonary artery.
Abbreviations: AA, ascending aorta; DA, descending aorta; LDPA, left descending pulmonary artery; PT, pulmonary trunk; RB, right bronchus; RPA, right pulmonary artery; 
SVC, superior vena cava.International Medical Case Reports Journal 2009:2 3
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next few days. Subsequent lung perfusion scan showed 
good perfusion of all lung units (Figure 2). UFH drip was 
switched to LMWH subcutaneously. The patient’s IVC ﬁ  lter 
was removed in the interventional radiology suite prior to 
discharge from hospital one month after its insertion.
Discussion
All patients with KTS are at high risk of DVT and PE and may 
require long term thromboprophylaxis.1,2 Anticoagulation is 
of vital importance in the perioperative setting or in trauma 
victims with this condition. Our patient developed massive 
PE despite the use of prophylactic anticoagulation with 
LMWH, which was interrupted only for 24 hours in the 
immediate peri-operative period.
PE in children is rare event and has not been extensively 
studied. The ﬁ  brinolytic system in the pediatric popula-
tion differs from the one in adults;3 however controlled 
studies are unavailable and treatment regimens of PE are 
usually extrapolated from the adult guidelines,4 which are 
outlined here.
The mainstay of PE therapy is anticoagulation with either 
UFH or LMWH.
In massive PE or where subcutaneous absorption is a 
concern, an intravenous UFH is a preferred antithrombotic 
agent. The recommended initial dose is an intravenous bolus 
of 80 units/kg followed by intravenous infusion 18 units/kg/h. 
Therapeutic effect is monitored by measuring either activated 
partial thromboplastin time or heparin levels. Subcutane-
ously administered LMWH is an effective alternative of 
UFH for treatment of PE in patients without hemodynamic 
compromise.
While antithrombotic agents or anticoagulants prevent 
further thrombus formation; clot dissolution is achieved 
by thrombolysis. Thrombolytic agents, also known as plas-
minogen activators, initiate ﬁ  brinolysis by conversion of 
plasminogen to plasmin, the main ﬁ  brinolytic enzyme. Since 
plasmin breaks ﬁ  brin in occlusive as well as hemostatic plug, 
bleeding may result.
Because of risk of hemorrhage and no mortality beneﬁ  t 
when compared to treatment with anticoagulants alone,4 
thrombolysis is recommended only in hemodynamically 
unstable PE with high risk of death and low risk of bleeding 
and in patients with poor prognosis due to right ventricular 
failure or severely compromised oxygenation.4 Agents with 
a short half-life, like tPA (T ½ = 5 min), are usually 
administered by infusion, while derivatives of tPA with 
longer half-life such as reteplase or TNK-t-PA (T ½ = 15 
and 20 minutes, respectively) may be given as a bolus.5 
Management of PE by means of interventional catheteriza-
tion techniques as well as surgical embolectomy should be 
restricted only to highly compromised patients who cannot 
receive thrombolytics.4
There are few case reports and case series depicting 
treatment of acute PE in children with thrombolytic agents6,7 
and surgical embolectomy.8 Cannizzaro and colleagues 
described an administration of tPA by catheter into two 
branches of PA in a 10-year-old girl with a massive PE and 
echocardiographic evidence of reduced right ventricular 
function.6 They used two boluses of tPA followed by a con-
tinuous infusion. Intravenous UFH was co-administered as 
an anticoagulant. Treatment with tPA was complicated by 
large hematoma in the groin area. Maeda and colleagues 
Table 1 Key hemodynamic parameters, gas exchange indicators, doses of inotropic agents as well as inhaled nitric oxide dose during 
and after an episode of PE
Event (PE) IR suite 12 h post event 24 h post event 48 h post event 96 h post event 5 days post event
MAP (mmHg) 50–60 65–68 60–65 60 s 60 s 65 68
HR (bpm) 106–132 90 117 110–120 100–125 100–120 100 s
PAPmean (mmHg) NA 30–32 NA 28 NA NA NA
paO2 (mmHg) 62 349 173 72.4 92 130 107
pETCO2 (mmHg) 24–28 NA NA NA NA NA NA
paCO2 (mmHg) 75 66–70 53 77.8 53 64 63
pH 7.23 7.25 7.35 7.18 7.40 7.31 7.33
Lactate (mmol/L) NA 0.6–0.8 NA NA NA NA NA
Dopamine (μg/kg/min) 0 0 5–10 5–10 5–16 0–5 0
Epinephrine (μg/kg/min) 0 0 0 0 0.05–0.1 0 0
iNO (ppm) 0 0 5–20 20–30 20 4–5 2
Abbreviations: HR, heart rate; iNO, inhaled nitric oxide; IR, interventional radiology; MAP, mean arterial pressure; PAPmean, mean pulmonary artery pressure; paO2, partial 
pressure of arterial oxygen; pETCO2, partial pressure of end-tidal carbon dioxide; paCO2, partial pressure of carbon dioxide; PE, pulmonary embolism.International Medical Case Reports Journal 2009:2 4
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administered thrombolytics successfully through the central 
venous catheter in a hemodynamically stable 4-year-old boy 
with poor oxygenation shortly after total cavopulmonary 
shunt.7 Combination of tPA (bolus) and urokinase (infusion) 
were used together with an infusion of UFH. Poor oxygen-
ation persisted and required treatment with iNO. Follow-up 
angiography revealed clot resolution.
We present a successful treatment of massive PE in 
a 3-year-old patient with oxygenation failure employing 
combination of interventional catheterization technique 
and regional thrombolysis. As we mentioned above, any 
embolectomy should be reserved only for highly unstable 
patients where thrombolytics are being contraindicated or 
has already failed. Our patient had signiﬁ  cantly compromised 
oxygenation, however thrombolytics were contraindicated 
because of recent major vascular resection and high risk of 
bleeding. Catheter extraction technique was chosen over an 
open approach since expertise was available, PA catheter 
was in situ (for selective pulmonary angiography) and the 
possibility of combining two techniques emerged. Risk of 
hemorrhage was weighed against the risk of signiﬁ  cant dam-
age and/or death from progressive hypoxemia and it was 
decided to proceed with thrombolysis. Availability of tPA, a 
thrombolytic agent that preferentially activates ﬁ  brin-bound 
plasminogen and not circulating plasminogen supported our 
treatment alternative. Streptokinase, urokinase, and reteplase 
do not have this discriminative property and resulting sys-
temic plasminemia causes degradation of ﬁ  brinogen and other 
clotting factors, and more bleeding. Nonetheless, the use of 
a ﬁ  brin-speciﬁ  c agent does not eliminate the risk of bleeding 
and an intervention should be undertaken only if all means for 
resuscitation including blood products and antiﬁ  brinolytics are 
immediately available. Procedure in this patient was performed 
by skilled interventional radiologist in fully equipped radiologi-
cal suite with on-site critical care specialist and stand-by blood 
products.
In vivo experiments show that flow in pulmonary 
circulation with embolus in its branches is almost instantly 
diverted into nonoccluded vessels.9 However fragmentation 
of the thrombus enables ﬂ  ow into previously occluded PA.9 
We believe that repeated administration of tPA contributed 
to sustained patency of PA based on the evidence that 
supports prolonged ﬁ  brinolysis after tPA administration 
despite its short half-life10 as well as the fact that the 
Anterior Posterior
Right lateral Left lateral LPO
RAO
Figure 2 Lung perfusion scan.
Abbreviations: RAO, right anterior oblique; LPO, left posterior oblique.International Medical Case Reports Journal 2009:2 5
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agent was injected into recently opened PA after catheter 
instrumentation.
To prevent recurrent PE, an IVC ﬁ  lter was inserted 
immediately after thrombolysis. Study of patients from the 
International Cooperative Pulmonary Embolism Registry 
(ICOPER) evaluated the effect of adjunctive therapies, such 
as thrombolysis and IVC ﬁ  lter placement on the clinical 
outcome of patients with massive PE.5 While thrombolytic 
therapy did not reduce mortality or recurrent PE, none of 
the patients with IVC ﬁ  lter developed recurrent PE and 
90-day mortality was reduced. It is unknown whether pre-
operative placement of the IVC ﬁ  lter in our patient would 
have prevented the thromboembolic episode and subsequent 
complications of therapy that we observed. In small children, 
IVC ﬁ  lter placement is technically challenging and carries 
the risk of IVC injury and thrombosis.11,12 As with adults, 
this technique does not provide complete protection against 
life-threatening PE.
Our patient developed RV dysfunction with elevated 
PA pressures as per TTE. Dopamine was started to support 
failing RV and iNO was initiated to unload the RV as well 
as improve VQ matching. Dose of iNO was titrated up to 
30 ppm to improve oxygenation. Weaning off iNO was a 
lengthy process lasting few days because of frequent episodes 
of desaturation initially.
Forty-eight hours after the embolectomy/thrombolysis, 
the patient experienced hypotension, hypoxemia, required 
higher doses of dopamine, and, for a short period of time, 
epinephrine. The exact nature of hypotension was not clear 
because the repeat angiography revealed patent right PA and 
TTE showed decreasing PA pressure, and improvement of 
right ventricular function. Some hypovolemia secondary to 
third space losses in this sick and very edematous patients 
might have been contributing factors.
Bleeding, which occurred three days after thrombolysis, 
was almost certainly related to use of anticoagulants, 
considering the short half life of thrombolytic agents. Discon-
tinuation of UFH, pressure dressing, and blood transfusions 
were the only measures to treat hemorrhage.
Conclusion
We present a unique management of PE in a child with 
oxygenation failure and recent major vascular surgery using 
a catheter extraction technique combined with regional 
thrombolysis followed by IVC ﬁ  lter placement. We believe 
that prompt diagnosis and expertise of hospital staff as well 
as availability of resources contributed to a good patient 
outcome in our case.
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